Cargando…
Echinocandins Localized to the Target-Harboring Cell Surface Are Not Degraded but Those Entering the Vacuole Are
[Image: see text] Echinocandin antifungal drugs have a broad spectrum of activities and excellent safety profiles. These agents noncompetitively inhibit the formation of the major polysaccharide component of the fungal cell wall, a reaction catalyzed by the membrane-bound β-glucan synthase (GS) prot...
Autores principales: | Jaber, Qais Z., Logviniuk, Dana, Yona, Adi, Fridman, Micha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127807/ https://www.ncbi.nlm.nih.gov/pubmed/35404573 http://dx.doi.org/10.1021/acschembio.2c00060 |
Ejemplares similares
-
Benzylic
Dehydroxylation of Echinocandin Antifungal
Drugs Restores Efficacy against Resistance Conferred by Mutated Glucan
Synthase
por: Logviniuk, Dana, et al.
Publicado: (2022) -
Elevated Vacuolar Uptake of Fluorescently Labeled
Antifungal Drug Caspofungin Predicts Echinocandin Resistance in Pathogenic
Yeast
por: Jaber, Qais Z., et al.
Publicado: (2020) -
Design Guidelines for Cationic Pillar[n]arenes that
Prevent Biofilm Formation by Gram-Positive Pathogens
por: Kaizerman-Kane, Dana, et al.
Publicado: (2021) -
Pan-Echinocandin Resistant C. parapsilosis Harboring an F652S Fks1 Alteration in a Patient with Prolonged Echinocandin Therapy
por: Siopi, Maria, et al.
Publicado: (2022) -
Azide‐Functionalized Derivatives of the Virulence‐Associated Sugar Pseudaminic Acid: Chiral Pool Synthesis and Labeling of Bacteria
por: Vibhute, Amol M., et al.
Publicado: (2021)